Luma Mahairi: AI and Digital Hematology Are Transforming Emergency Laboratory Care in 2026
Luma Mahairi, Clinical Research Coordinator III at DM Clinical Research, shared on LinkedIn about a recent article by Ganna Shestakova et al, published in International Journal of Laboratory Hematology, adding:
”One of the most important changes coming to hematology practice in 2026 is the way laboratories will manage hematologic emergencies faster, earlier, and more proactively through automation, digital hematology, and AI-supported workflows.
We are moving away from a purely reactive model of lab medicine toward real-time risk detection and integrated clinical decision support.
Key changes already emerging include:
- AI-assisted peripheral smear review and blast detection
- Earlier identification of acute leukemia, DIC, sepsis-associated coagulopathies, and thrombotic emergencies
- Automated flagging systems for critical CBC/coagulation abnormalities
- Digital hematopathology platforms that improve turnaround time and diagnostic consistency
- Smarter triaging of STAT specimens and emergency hematology workflows
- Integration of molecular, coagulation, and morphology data into unified laboratory dashboards
- Reduced manual review burden through intelligent automation and image analysis
This is especially important in hematology emergencies, where minutes matter.
Faster recognition of blasts, hemolysis, thrombocytopenia, coagulopathies, hyperleukocytosis, or transfusion-related complications can significantly improve patient outcomes.
The hematology laboratory of 2026 is becoming less of a passive testing center and more of an active clinical intelligence hub supporting emergency decision-making in real time.”
Title: Common Hematologic Emergencies – Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias – A Pivotal Role of Clinical Laboratory
Authors: Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy